Results of 188 Whole-Body Fluorodeoxyglucose Positron Emission Tomography Scans in 137 Patients With Sarcoidosis
Top Cited Papers
- 1 December 2007
- Vol. 132 (6) , 1949-1953
- https://doi.org/10.1378/chest.07-1178
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine Positron Emission Tomography in Combination With 18 F-Fluorodeoxyglucose in Sarcoidosis PatientsChest, 2007
- Value of FDG Positron Emission Tomography in Monitoring the Effects of Therapy in Progressive Pulmonary SarcoidosisClinical Nuclear Medicine, 2007
- F-18 FDG PET Imaging of Disseminated SarcoidosisClinical Nuclear Medicine, 2007
- Positron emission tomography myocardial perfusion and glucose metabolism imagingJournal of Nuclear Cardiology, 2006
- Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardiaThe International Journal of Cardiovascular Imaging, 2006
- False-Positive FDG PET Uptake−the Role of PET/CTEuropean Radiology, 2005
- Statement on SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Lung Function Testing: Selection of Reference Values and Interpretative StrategiesAmerican Review of Respiratory Disease, 1991
- Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis.Circulation, 1984
- Prognosis of Intrathoracic Sarcoidosis in EnglandBMJ, 1961